Federica Saletta

High Street
Randwick, NSW 2052, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Coupling redox regulation with Cancer immunotherapy: The challenge of polyphenol Nanocarriers.

Coupling redox regulation with Cancer immunotherapy: The challenge of polyphenol Nanocarriers.

Journal: Advanced drug delivery reviews
Published: June 19, 2026

Correction: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Correction: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Journal: Oncogene
Published: March 03, 2025

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Copper chelation redirects neutrophil function to enhance anti-GD2 antibody therapy in neuroblastoma.

Journal: Nature communications
Published: February 19, 2024

CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers.

Journal: Oncogene
Published: February 14, 2024

Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer.

Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-β signaling pathways in cancer.

Journal: Cell & bioscience
Published: January 25, 2023

A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.

A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer.

Journal: Genome medicine
Published: October 13, 2022

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.

Journal: Frontiers in pharmacology
Published: September 13, 2022

In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.

In vitro and in vivo drug screens of tumor cells identify novel therapies for high-risk child cancer.

Journal: EMBO molecular medicine
Published: May 28, 2021

Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and ALK Genotyping via Cell-Free Circulating Tumor DNA Profiling.

Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and ALK Genotyping via Cell-Free Circulating Tumor DNA Profiling.

Journal: Cancers
Published: May 23, 2021

Dextran-Curcumin Nanosystems Inhibit Cell Growth and Migration Regulating the Epithelial to Mesenchymal Transition in Prostate Cancer Cells.

Dextran-Curcumin Nanosystems Inhibit Cell Growth and Migration Regulating the Epithelial to Mesenchymal Transition in Prostate Cancer Cells.

Journal: International journal of molecular sciences
Published: May 20, 2021

Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer.

Rare germline variants in childhood cancer patients suspected of genetic predisposition to cancer.

Journal: Genes, chromosomes & cancer
Published: May 03, 2021

Copper: An Intracellular Achilles' Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics.

Copper: An Intracellular Achilles' Heel Allowing the Targeting of Epigenetics, Kinase Pathways, and Cell Metabolism in Cancer Therapeutics.

Journal: ChemMedChem
Published: March 09, 2021
Showing 1-12 of 29

Last Updated: 09/26/2026